These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24845383)
21. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387 [TBL] [Abstract][Full Text] [Related]
22. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048 [TBL] [Abstract][Full Text] [Related]
23. A platelet secretion pathway mediated by cGMP-dependent protein kinase. Li Z; Zhang G; Marjanovic JA; Ruan C; Du X J Biol Chem; 2004 Oct; 279(41):42469-75. PubMed ID: 15280395 [TBL] [Abstract][Full Text] [Related]
25. Effect of cGMP analogues and protein kinase G blocker on secretory activity, apoptosis and the cAMP/protein kinase A system in porcine ovarian granulosa cells in vitro. Sirotkin AV; Makarevich AV; Pivko J; Kotwica J; Genieser H; Bulla J J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):1-9. PubMed ID: 11074350 [TBL] [Abstract][Full Text] [Related]
26. 8-pCPT-cGMP stimulates alphabetagamma-ENaC activity in oocytes as an external ligand requiring specific nucleotide moieties. Nie HG; Zhang W; Han DY; Li QN; Li J; Zhao RZ; Su XF; Peng JB; Ji HL Am J Physiol Renal Physiol; 2010 Feb; 298(2):F323-34. PubMed ID: 20007351 [TBL] [Abstract][Full Text] [Related]
27. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets. Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165 [TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. Komalavilas P; Lincoln TM J Biol Chem; 1996 Sep; 271(36):21933-8. PubMed ID: 8702997 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418 [TBL] [Abstract][Full Text] [Related]
30. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures. John TA; Ibe BO; Raj JU Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503 [TBL] [Abstract][Full Text] [Related]
31. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway. Aburima A; Walladbegi K; Wake JD; Naseem KM J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344 [TBL] [Abstract][Full Text] [Related]
33. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts. Huang JS; Chuang LY; Guh JY; Chen CJ; Yang YL; Chiang TA; Hung MY; Liao TN J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724 [TBL] [Abstract][Full Text] [Related]
34. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets. Kleppe R; Jonassen I; Døskeland SO; Selheim F Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984 [TBL] [Abstract][Full Text] [Related]
35. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Draijer R; Vaandrager AB; Nolte C; de Jonge HR; Walter U; van Hinsbergh VW Circ Res; 1995 Nov; 77(5):897-905. PubMed ID: 7554143 [TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle. Ibe BO; Ameer A; Portugal AM; Renteria L; Raj JU J Pharmacol Exp Ther; 2007 Feb; 320(2):728-37. PubMed ID: 17085546 [TBL] [Abstract][Full Text] [Related]
37. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets. Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647 [TBL] [Abstract][Full Text] [Related]
38. Activation of the small GTPase Rac1 by cGMP-dependent protein kinase. Hou Y; Ye RD; Browning DD Cell Signal; 2004 Sep; 16(9):1061-9. PubMed ID: 15212766 [TBL] [Abstract][Full Text] [Related]
39. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein. Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178 [TBL] [Abstract][Full Text] [Related]
40. The NO/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I. Danielewski O; Schultess J; Smolenski A Thromb Haemost; 2005 Feb; 93(2):319-25. PubMed ID: 15711749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]